3B Future Health Fund

Investment Focus

Investment Stages

Geographic Focus

Europe

Inferred Thesis

Auto-generated from public data. Not the firm's stated position.

3B Future Health Fund appears to focus on early-stage healthtech and edtech investments in the €0.1M to €1.5M range, with recent portfolio activity suggesting a concentration in specialized therapeutic areas including oncology, rare diseases, and immunotherapy.

Generated 2 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].

How to Pitch 3B Future Health Fund

No Stated Policy
3B Future Health Fund hasn't published an outreach policy. A short, specific cold email is the safest default.

Portfolio Highlights

Carthera - ultrasound oncology
Minoryx - rare diseases
Anaveon - immunotherapy

Focus and check size from the firm's website. Website reachable as of Oct 2026.

Ready to Reach 3B Future Health Fund?

A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.